Madjarov Jeko M, Katz Michael G, Poole Brad, Madzharov Svetozar, Fedor John M, Robicsek Francis
Department of Cardiothoracic Surgery, Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States.
Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Thorac Cardiovasc Surg. 2017 Sep;65(6):475-478. doi: 10.1055/s-0037-1601313. Epub 2017 Mar 21.
The indications for placement of an implantable cardioverter defibrillators (ICDs) have greatly expanded over the last years. However, standard transvenous approach is not suitable for a subset of patients who cannot benefit from ICD therapy. Here, we have demonstrated the feasibility and efficacy of extrapericardial ICD placement through a minimally invasive access in intact hearts as well as in postmyocardial infarction large animal models. Based on our data, we conclude that extrapericardial ICD placement is a feasible approach that may be a valuable alternative or adjunct to current defibrillator lead systems.